Merck KGaA Builds Plant in Switzerland

19:38 PM | January 24, 2007 | Chemical Week Editorial Staff

Merck KGaA says it will build a plant near Geneva to manufacture the company’s Erbitux monoclonal antibody cancer treatment. The announcement was made shortly after Merck KGaA completed the...